Eurasian Journal of Chemical, Medicinal and Petroleum Research

Abstract The present study examined the iodine diet in patients with hyperthyroidism. Hyperthyroidism is a serious disease that occurs due to dysfunction of the thyroid gland and increased production of thyroid hormone. This disease is usually treated with ant thyroid drugs and, if necessary, surgery. However, a healthy diet can also have a positive effect on improving the health of patients and their condition. For this reason, experts usually recommend that patients with hyperthyroidism follow a diet suitable for hyperthyroidism, along with other treatment options. The amount of radioactive iodine used to control thyroid diseases can vary depending on the individual's disease, so that in some diseases the dose can be without side effects. A proper diet can take steps to eliminate substances that aggravate the symptoms of hyperthyroidism and help improve the symptoms of the disease. A major problem in the diet of people with hyperthyroidism is controlling the amount of iodine intake. In some cases, doctors believe that the presence of excessive amounts of iodine can be effective in cases of hyperthyroidism, and therefore controlling the amount of iodine in the diet can help relieve the symptoms of the disease. The results showed that hyperthyroidism can cause obvious weight loss and make it difficult to gain weight. This is because the body's metabolism increases in this disease. The obvious connection between diet and hyperthyroidism is the presence of iodine in the diet. There are many reasons for the belief that iodine can increase the likelihood of developing hyperthyroidism. On the other hand, Graves' disease has an interesting connection with gluten. Diet can be useful for minimizing the damage caused by hyperthyroidism, especially brittle bones.

Abstract The development of renewable energy in Iran is of great importance due to its favorable geographical conditions and the need for sustainable energy sources, and the integration of renewable energy sources in oil and gas operations will create a sustainable future for future generations. The world is at a critical juncture where the demand for energy intersects with the urgent need to combat climate change. Traditional energy sources, dependent on fossil fuels, significantly contribute to greenhouse gas emissions and environmental degradation. In response, there is a paradigm shift towards renewable energy sources such as solar, wind, hydro, and geothermal energy. Programming, in conjunction with technological innovations, plays a pivotal role in the use and optimization of these renewable energy solutions. The role of programming in renewable energy solutions is not just supportive but also transformative. From designing efficient systems and optimizing energy production to enabling smart grids and harnessing the power of artificial intelligence, programming is the main axis that drives the renewable energy revolution forward. As the world increasingly embraces sustainable energy sources, the challenges and opportunities for programming in this area continue to expand. By leveraging the capabilities of programming languages, frameworks, and emerging technologies, developers can help create a cleaner and more sustainable energy future. As we navigate the complexities of climate change, programming becomes an essential tool that enables us to harness the potential of renewable energy and lead the global transition to a more sustainable and resilient energy ecosystem.

Abstract Lithium-ion batteries have changed the landscape of energy storage and ushered in a new era of clean, efficient and sustainable energy solutions. From powering our smartphones and laptops to fueling the transportation and renewable energy sectors, lithium-ion batteries are essential to modern life. The main goal of the innovative technology is to solve one of the old challenges of the battery industry: The erosion of liquid electrolytes. As research and innovation continue to push the boundaries of battery technology, the future holds exciting opportunities for even more efficient, safer and environmentally friendly energy storage solutions. By harnessing the potential of lithium-ion batteries, we can pave the way to a greener and more electrified future for generations to come. Additionally, this solution can improve battery safety by reducing the risk of thermal runaway – a common concern in older lithium-ion batteries. This development is in line with phenomena such as the global determination for sustainable energy solutions as well as the increasing demand for high-performance batteries.

Abstract Genetic technologies in personalized medicine have revolutionized the management of anticoagulant therapy. Despite their vital role in preventing blood clots, these drugs pose numerous challenges in dose adjustment and side effect management due to the varying responses of patients. Genetic analysis has enabled the provision of personalized, safer, and more effective therapy by identifying genetic differences in related genes such as CYP2C9 and VKORC1. By precisely adjusting the dose, reducing side effects, accelerating the treatment process, and reducing costs, this technology not only improves the quality of life of patients but also paves the way for new standards in healthcare. However, challenges such as high costs, limited access, and privacy issues require attention and resolution. In this approach, the genome of the individual in question is compared with reference genomes, and based on the information obtained, the individual can be treated in an appropriate and specific way. In fact, the genetic nature of the individual determines the treatment strategy. One aspect of personalized medicine is the use of pharmacogenomics. In this method, a more appropriate and informed drug is provided by using and knowing the sequence of an individual's genome. In conventional medicine, drugs are often prescribed with the idea that the effect of the drug is the same for everyone, but in fact this is not the case and each person responds differently to the drug depending on the nature of their genome sequence. Therefore, various factors must be taken into account. For example, depending on these sequences, side effects, the required amount of drug, the likelihood of successful treatment, and the prognosis of the disease will all be unique to each individual.

Abstract Coronaviruses are a large family of viruses that, according to evidence, can cause diseases ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) or even more severe diseases such as Severe Acute Respiratory Syndrome (SARS). Epidemiology A disease, whether contagious or non-contagious, may be more or less common in some areas and under some conditions among a large number of people. In other words, a disease can be more or less common. The science that studies how diseases spread and what causes them to spread is called epidemiology, which is a branch of medical science. Basically, epidemiology seeks to prevent the occurrence and spread of a disease or to control it if it does spread. Communicable diseases are a type of infectious disease that can be transmitted from person to person or to humans through insects and other animals. This disease can also be transmitted by organisms in contaminated water or food that has been exposed to the environment by an infected person. For example, a sick child's cough is one way to transmit a cold or flu to others, which must be well taken care of and prevented. In general, the factors that because infectious diseases include viruses, bacteria, and parasites. The signs and symptoms of infectious diseases will also vary depending on the agent causing the infection.

Abstract One of these new concepts that was created with the increasing development of medical science and biological knowledge was “Regenerative Medicine”, which is referred to as the medicine of the future. It has been less than 20 years since the concept of regenerative medicine entered the medical field and has become one of the areas of interest of universities, research centers, and biotechnology and pharmaceutical companies. Regenerative medicine seeks to find new methods of preventing, diagnosing, and treating diseases, so that it can move from traditional medicine that works around the diagnosis and treatment with chemical and, to some extent, biotechnological drugs, towards individual-centered medicine and even precision medicine, for which biological products and drugs will play an important role. Despite the extensive advances in medical science, a significant number of human diseases are still incurable and only the symptoms of the disease are controlled. Therefore, regenerative medicine tries to treat these diseases definitively by using the same tools that the body naturally uses to repair damaged tissues and organs. These tools include: body cells, the material that surrounds cells in their natural habitat, and molecules that affect cells. Stem cells are one type of cell used in this field and have received special attention due to their great ability to transform into other cells and repair damaged areas. Stem cells play a major role in the development of organisms from the embryonic period and these cells can be identified in body tissues both during the embryonic period and after birth and are responsible for maintaining cellular balance in the normal state as well as during the process of repairing a tissue after disease.

Abstract Asthma is a chronic inflammatory disease of the airways characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and underlying inflammation. This condition affects millions worldwide, leading to significant morbidity and healthcare costs. Traditional therapies, such as inhaled corticosteroids (ICS) and bronchodilators, have long been the cornerstone of asthma management. These medications primarily aim to reduce inflammation and relax airway muscles, providing symptomatic relief and preventing exacerbations. However, a subset of patients with severe asthma remains inadequately controlled despite optimal conventional therapy. This unmet need has spurred the development of novel pharmacological agents targeting specific pathways involved in asthma pathophysiology. These novel drugs include biologics, small molecules, and new inhaled formulations. Biologics, such as anti-IL-5, anti-IL-4/IL-13, and anti-IgE therapies, offer targeted treatment options for patients with severe asthma by modulating specific immune responses. Small molecule drugs, like PDE4 inhibitors and tyrosine kinase inhibitors, provide new mechanisms to control inflammation and bronchoconstriction. Additionally, advancements in inhaler technology and formulation have led to the development of new inhaled therapies, improving drug delivery and efficacy. This review discusses these novel drugs, highlighting their mechanisms of action, efficacy, and safety profiles, offering hope for better asthma management and improved patient outcomes.